eprodisate

Eprodisate is a novel compound specifically developed to disrupt the interactions between amyloidogenic proteins and glycosaminoglycans, effectively impeding the polymerization of amyloid fibrils and their deposition in tissues. This compound shows potential for delaying the advancement of AA amyloidosis-related renal disease and could apply to various forms of amyloidosis.

Eprodisate disodium (NC-503) 是一种带负电荷的磺化类的原纤维形成抑制剂，是口服具有活力的 Eprodisate 二钠盐形式，可用于研究淀粉样蛋白A(AA) 淀粉样变性病。